本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Trillium Therapeutics Inc.

18.44
+0.0000
成交量:- -
成交額:4.82億
市值:19.36億
市盈率:-34.05
高:18.44
開:18.44
低:18.44
收:18.44
資料載入中...
2019/11/14

員工持股計劃

Securities to be offered to employees in employee benefit plans
2019/11/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/04

超過5%披露

[Amend] General statement of acquisition of beneficial ownership